Genoray Co., Ltd. (KOSDAQ:122310)

Market Cap	72.19B
Revenue (ttm)	108.97B
Net Income (ttm)	7.63B
Shares Out	12.73M
EPS (ttm)	564.44
PE Ratio	10.05
Forward PE	n/a
Dividend	160.00 (2.82%)
Ex-Dividend Date	Apr 2, 2025

Volume	6,396
Average Volume	9,606
Open	5,600.00
Previous Close	5,590.00
Day's Range	5,530.00 - 5,600.00
52-Week Range	5,250.00 - 6,970.00
Beta	0.65
RSI	51.79
Earnings Date	Feb 26, 2025

About Genoray

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2001
• Employees: 346
• Stock Exchange: KOSDAQ
• Ticker Symbol: 122310

Financial Performance

In 2023, Genoray's revenue was 97.90 billion, an increase of 18.51% compared to the previous year's 82.60 billion. Earnings were 12.49 billion, a decrease of -10.17%.